What Happens to Breast Implants When You Get Old?

Breast implants do not age gracefully on their own. Over decades, the devices gradually degrade while the body around them changes too: skin loses elasticity, breast tissue thins, scar tissue thickens, and the risk of rupture climbs steadily with each passing year. By around the ten-to-fifteen-year mark, a significant share of implants will have developed at least one complication requiring medical attention, and reoperation rates in the range of 20 to 40 percent at ten years are well documented. None of this means implants are ticking time bombs, but it does mean that growing old with implants involves a distinct set of considerations that most people never think about at the time of their original surgery.

How Rupture Risk Climbs Over Time

The single most predictable thing about breast implants is that the longer they stay in your body, the more likely they are to rupture. In a study using high-resolution ultrasound on 584 women, about 3 to 5 percent of implants placed within the previous three to six years already showed signs of rupture. For implants that had been in place fourteen to sixteen years, that figure jumped to between 25 and 50 percent.¹ The trend is steady, not sudden: rupture does not happen all at once at some magic expiration date. It accumulates year over year as the silicone shell fatigues, folds repeatedly in the same spots, and slowly weakens.

An important nuance here is that most silicone implant ruptures are “silent,” meaning you cannot feel or see them. Modern cohesive-gel implants hold their shape better than the liquid-gel implants of earlier generations, so when the shell breaks, the filling often stays put rather than spilling visibly. This is precisely why the FDA updated its surveillance recommendations in 2020 to call for an ultrasound or MRI five to six years after silicone implant placement, with repeat screening every two to three years after that.² The screening burden is real, and many women with decades-old implants have never followed that schedule.

Silicone Does Not Stay Where It Was Put

Even when an implant has not technically ruptured, silicone can migrate. The phenomenon is called “gel bleed,” and it happens when microscopic silicone particles seep through the intact shell and into surrounding tissues. A Dutch study of 389 women undergoing implant removal or revision found that nearly 99 percent had silicone particles present in their tissues, and in about 87 percent, those particles had traveled beyond the scar capsule surrounding the implant and into nearby tissue or lymph nodes.³ This migration occurred regardless of whether the implants were older or newer cohesive-gel designs.

Research on the material science side confirms that the shell itself changes over time. As a silicone implant ages inside the body, low-molecular-weight silicone compounds gradually migrate from the gel core into the shell and beyond. Older second-generation implants with thinner shells showed particularly high “bleeding” rates, which lab measurements could detect as changes in the shell’s rigidity and thermal behavior.⁴ Newer implants with thicker, more crosslinked shells do bleed less, but the Dutch data make clear they still bleed. The clinical significance of small-scale silicone migration in otherwise healthy women remains debated, but the finding undercuts any assumption that an intact implant is a perfectly sealed container.

Capsular Contracture and What Happens to Scar Tissue

Your body treats a breast implant as a foreign object and walls it off with a layer of scar tissue called the capsule. In many women this capsule stays thin and soft. In others it tightens, thickens, and squeezes the implant, making the breast feel hard, look distorted, or cause pain. This process, capsular contracture, is the most common reason women with implants end up back in the operating room. Over a ten-year follow-up, the estimated risk of clinically significant contracture was about 11.5 percent for women who had implants for cosmetic augmentation and roughly 25 percent for those who had implants placed after mastectomy.⁵ A separate large series found that about 27 percent of augmentation patients developed some grade of contracture over a follow-up of up to sixteen years.⁶

Age itself seems to accelerate the process. One study found that women who were 40 or older at the time of their original augmentation developed capsular contracture an average of about 12 years later, compared with nearly 19 years for women who were younger at the time of surgery.⁷ In other words, an older body builds that problematic scar tissue faster. In very long-standing cases, the capsule can even calcify, forming a hard shell of calcium deposits around the implant. A case report described this in an 81-year-old patient, where the calcification was dense enough to show up clearly on imaging.⁸

The reconstructive context matters here. FDA postapproval data covering nearly 100,000 patients showed that at seven years the reoperation rate was about 12 percent for women with cosmetic augmentation and 25 percent for women with implants placed after mastectomy, with capsular contracture being the leading reason for reoperation in augmentation patients.⁹ Women who had reconstruction after cancer treatment face higher complication rates partly because radiation, tissue handling, and the biology of the surgical site all promote more aggressive scarring.

Your Breast Tissue Changes Around the Implant

Implants do not just sit passively inside an unchanging breast. The pressure an implant exerts on the surrounding glandular tissue actually causes that tissue to thin. Researchers measuring breast volume by MRI found that within just twelve months of implant insertion, glandular tissue volume dropped by about 13 percent, and the degree of thinning correlated with the amount of pressure the implant placed on the tissue.¹⁰ Over decades, this implant-driven atrophy compounds the natural age-related loss of breast tissue, where glandular tissue is gradually replaced by fat and the skin stretches and loosens.

The practical result is that if you eventually have your implants removed later in life, there is substantially less native breast tissue left than there would have been without the implants. The breast may look deflated, saggy, or markedly different from what was there before augmentation. This is one of the harder truths of long-term implant ownership: the implant slowly reshapes the landscape it sits in, and you cannot simply return to your starting point by taking it out.

What Happens to Implants That Have Been in Place for Decades

Some women go twenty, thirty, or even forty years without having their implants addressed. A case report documented the removal of silicone implants that had been in place for 40 years in a 70-year-old woman. Both implants had ruptured, and examination revealed siliconoma (a granuloma formed around leaked silicone) with lymphoid hyperplasia and calcification in both breasts, though no malignancy was found.¹¹ Cases like this are increasingly common as the population of women who received implants in the 1980s and 1990s reaches their sixties and seventies.

These legacy implants from earlier generations tend to be more problematic than modern ones. Thinner shells, less cohesive gel fills, and manufacturing techniques that have since been abandoned all contribute to higher rates of rupture and silicone migration. But even with newer implants, no device is meant to last a lifetime, and the FDA has never approved any breast implant as a permanent device.

Cancer Screening Gets Harder

Mammography becomes more important as you age, and implants make it harder. The implant physically blocks the X-ray from reaching some breast tissue, reducing how much the radiologist can see. A special technique called the Eklund maneuver (or implant-displacement view) pushes the implant back and pulls the breast tissue forward, gaining roughly an extra centimeter of visible tissue on each view.¹² That helps, but the displacement is limited, and in women with severe capsular contracture the implant may not push back at all.

This reduced visibility is not just a theoretical concern. Implants lower the sensitivity of mammography, and women with implants need individualized imaging strategies that distinguish cancer screening from device surveillance.¹³ Digital breast tomosynthesis (3D mammography) can add some diagnostic value for non-displaced views in augmented breasts, though research suggests the cancer detection rate with and without it was similar in one study, with one additional cancer found when the 3D images were included.¹⁴ For women in their fifties, sixties, and beyond, when breast cancer risk is climbing, this screening limitation is one of the most underappreciated costs of keeping implants long-term.

The Rare but Real Risk of BIA-ALCL

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare cancer of the immune system that forms in the scar capsule around breast implants. It is not breast cancer, but a type of lymphoma. The disease is most strongly linked to textured-surface implants, and lifetime risk estimates for women with textured implants range from about 1 in 1,000 to 1 in 30,000.¹⁵ The average age at diagnosis is around 55, with a mean time from first implant placement to disease onset of about ten years.¹⁶

The key warning sign is a late seroma, an unexplained fluid collection around the implant that appears more than a year after surgery. Any woman with longstanding implants who notices one breast suddenly swelling should have it evaluated promptly. BIA-ALCL is highly treatable when caught early, usually by removing the implant and the entire capsule, but delayed diagnosis makes outcomes worse. The risk becomes increasingly relevant with age simply because the implants have been in the body longer, giving the disease more time to develop.

Autoimmune Concerns and “Breast Implant Illness”

For decades, some women have reported systemic symptoms they attribute to their breast implants: joint pain, fatigue, brain fog, skin rashes, and other complaints that overlap with autoimmune conditions. The medical literature on this has been contentious. A large US retrospective study found that breast implant patients self-reported connective tissue disorders such as rheumatoid arthritis and scleroderma at roughly double the rate of comparison patients who had undergone other cosmetic surgery. However, when an expert panel reviewed the medical records, only a minority of those self-reports met the clinical criteria for a confirmed diagnosis, and the recalculated risk differences were no longer statistically significant.¹⁷

That does not settle the debate. Many women report clear symptom improvement after explantation (implant removal), and a study of symptom outcomes after capsulectomy found that patients reported similar levels of improvement regardless of whether the entire capsule or only part of it was removed.¹⁸ The honest assessment is that the connection between implants and systemic symptoms remains plausible but unproven at a population level, while clearly real for some individuals. For older women dealing with the overlapping fatigue and joint pain that come with menopause and aging, distinguishing implant-related symptoms from age-related ones can be genuinely difficult.

Surgery Gets Riskier as You Age

Whether you are having implants replaced, removed, or repaired, surgery itself becomes more hazardous with age. Older skin heals more slowly, blood supply to tissue flaps is less robust, and comorbidities like diabetes or heart disease raise the stakes. Research quantifying these risks found that for every additional year of age between 40 and 70, the rate of mastectomy skin flap necrosis rises by about 2 percent and infection risk rises by about 1 percent. By the time a woman reaches 70, the overall postoperative complication rate for implant-based procedures can be roughly double that of younger patients.¹⁹

A study specifically looking at immediate breast reconstruction in women aged 70 and older found a major complication rate of about 18 percent, including a 10 percent rate of implant removal.²⁰ These numbers do not mean surgery is off the table for older women, but they do mean the risk-benefit calculation shifts. A 75-year-old with an asymptomatic ruptured implant faces a different decision than a 50-year-old with the same finding.

When Screening Can Reasonably Stop

One question that often goes unasked is whether there is an age at which you can stop worrying about implant surveillance. A recent scoping review proposed a practical set of recommendations: surveillance screening for silicone implant rupture in women without symptoms could reasonably be discontinued after age 75. The same review suggested that asymptomatic women over 75 with known or suspected rupture could be followed clinically without further imaging unless symptoms develop, and that routine implant exchange is not warranted in this age group.¹⁹ The logic is straightforward: if the risks of surgery exceed the risks of leaving a ruptured but asymptomatic implant alone, the best course is watchful waiting. This is a shared decision between patient and surgeon, not a blanket rule, but it acknowledges that the calculus changes meaningfully in later life.

Options If You Want Your Implants Out

Women who decide to have their implants removed in their fifties, sixties, or later face the question of what comes next. Simply removing the implants (explantation) without doing anything else typically leaves the breasts looking deflated, because of the tissue atrophy and skin stretching described earlier. Several surgical strategies can help.

One increasingly popular approach combines a breast lift (mastopexy) with fat grafting, where fat harvested from elsewhere on the body is injected into the breast to restore some volume. A study of 26 women with a mean age of 59 who underwent this combination after implant removal reported no major complications over an average follow-up of 18 months, with an average of about 258 cc of fat injected per breast.²¹ Another option is autologous tissue reconstruction, using tissue flaps from the abdomen or back to rebuild the breast mound. Women who converted from implant-based reconstruction to autologous tissue reported significantly higher satisfaction with the appearance of their breasts compared with women who simply had their implant swapped for a new one.²²

These procedures are more involved than a straightforward explantation, and the surgical risks described above apply. But for women who are done with implants and want a result they are happy with, these options exist and the satisfaction data are encouraging.

How Aging Women Feel About Their Implants

The emotional dimension of aging with breast implants is less studied than the physical one, but some data exist. In a large Australian study of breast reconstruction patients, those with autologous tissue reported greater satisfaction with their breasts than those with implant-based reconstruction, though both groups reported good overall quality of life and low levels of regret.²³ A Japanese multicenter study found that decision regret following breast reconstruction increases slightly with advancing age, regardless of the surgical method used.²⁴

Interestingly, what drives regret is not usually the reconstruction itself but complications. Women who experienced postoperative problems reported significantly greater regret than those who did not, independent of whether they had implants or autologous tissue.²⁵ This suggests that the best way to stay satisfied with your implants over the long haul is to stay informed about complication risks and address problems early, rather than waiting until a small issue becomes a large one. The women who tend to be least happy decades later are not necessarily those who chose implants, but those who were never told what to expect from them over time.